Private clinics prescribing high-potency cannabis clearly have a duty of care to monitor patients closely. In this case, the involvement of Curaleaf Clinic highlights the risks of remote consultations and minimal follow-up, which can create dangerous gaps for vulnerable individuals. Clinics should be held accountable when their practices contribute to serious harm, and stricter regulations like mandatory mental health screenings, dosage limits, and regular check-ins seem essential. Research shows that cannabis addiction risk increases with high-THC products and lack of oversight, so cases like this underline the need for systemic safeguards to prevent such tragic outcomes.
